Omvoh (mirikizumab) for Ulcerative Colitis: US FDA Approved Treatment Explained

FDA Approves Mirikizumab, a Promising Induction and Maintenance Therapy for Ulcerative ColitisПодробнее

FDA Approves Mirikizumab, a Promising Induction and Maintenance Therapy for Ulcerative ColitisПодробнее

FDA Approves Entyvio for IBD Patients -- IBD in the NewsПодробнее

How to Manage Ulcerative Colitis Without MedicationПодробнее

FDA Approves Ozanimod for Ulcerative ColitisПодробнее

Novel Targets and Therapeutic Perspectives in IBD: Beyond Anti-TNFПодробнее

Living with Ulcerative Colitis – Nour’s StoryПодробнее

FDA approves NEW NOVEL treatments for Ulcerative Colitis | VELSIPITY | OMVOH | Pharmacist ReviewПодробнее

Efficacy and safety of mirikizumab in psoriasis: OASIS-1, A. Blauvelt et alПодробнее

Ulcerative Colitis Medications | 3D Medical Animation | Pixeldust StudiosПодробнее

What Crohn's Disease and Ulcerative Colitis Medications Will Be Available in the Future?Подробнее

Newer therapies on the horizon for Inflammtory Bowel DiseaseПодробнее

Maria Abreu, MD: Ustekinumab as a First Line Treatment for Ulcerative ColitisПодробнее

Pfizer's VELSIPITY Granted FDA Approval for Moderate to Severe Active Ulcerative Colitis in AdultsПодробнее

David's Journey to Freedom from Ulcerative ColitisПодробнее

FDA approves Rinvoq as first pill to treat moderate-to-severe Crohn's DiseaseПодробнее

Loqtorzi, Vabysmo, Omvoh, Vamorolone, Tibsovo, FluMistПодробнее

FDA Approves Biosimilar to Humira – IBD in the NewsПодробнее